- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/02 - Preparation by ring-closure or hydrogenation
Patent holdings for IPC class C07D 211/02
Total number of patents in this class: 80
10-year publication summary
|
4
|
5
|
11
|
5
|
3
|
3
|
2
|
5
|
4
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 21129 |
5 |
| Florida State University Research Foundation, Inc. | 822 |
4 |
| Janssen Pharmaceutica N.V. | 3234 |
3 |
| Tesaro, Inc. | 106 |
3 |
| Northwestern University | 3512 |
2 |
| MyCell Technologies, LLC | 5 |
2 |
| Nanyang Technological University | 2158 |
2 |
| Unichem Laboratories Limited | 92 |
2 |
| Universite Claude Bernard Lyon 1 | 1067 |
2 |
| Xinfa Pharmaceutical Co., Ltd. | 22 |
2 |
| Merck Sharp & Dohme LLC | 3723 |
2 |
| Specialty Operations France | 898 |
2 |
| L'OREAL, Société Anonyme | 16205 |
1 |
| Merck Sharp & Dohme Corp. | 2184 |
1 |
| Massachusetts Institute of Technology | 10201 |
1 |
| Sumitomo Chemical Company, Limited | 9055 |
1 |
| Alembic Limited | 43 |
1 |
| Asymchem Laboratories (Tianjin) Co., Ltd | 109 |
1 |
| Asymchem Life Science (Tianjin) Co., Ltd | 88 |
1 |
| Concert Pharmaceuticals, Inc. | 245 |
1 |
| Other owners | 41 |